NEW YORK (GenomeWeb News) – CombiMatrix yesterday reported a 9 percent dip in third-quarter revenues amid a double-digit decline in R&D spending and a smaller net loss.
 
For the quarter ended Sept. 30 -- its first as a standalone firm after splitting from Acacia Research in August -- revenue fell 9 percent to $1.7 million from $1.8 million in the comparable period of 2006.
  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.